- Home
- CTRM vs IBO Comparison
CTRM vs IBO Comparison
Compare CTRM & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- IBO
- Stock Information
- Founded
- CTRM 2016
- IBO 2018
- Country
- CTRM Cyprus
- IBO United States
- Employees
- CTRM N/A
- IBO N/A
- Industry
- CTRM Marine Transportation
- IBO
- Sector
- CTRM Consumer Discretionary
- IBO
- Exchange
- CTRM Nasdaq
- IBO NYSE
- Market Cap
- CTRM 25.0M
- IBO 22.1M
- IPO Year
- CTRM N/A
- IBO 2024
- Fundamental
- Price
- CTRM $2.38
- IBO $0.69
- Analyst Decision
- CTRM
- IBO
- Analyst Count
- CTRM 0
- IBO 0
- Target Price
- CTRM N/A
- IBO N/A
- AVG Volume (30 Days)
- CTRM 50.0K
- IBO 28.6K
- Earning Date
- CTRM 03-18-2025
- IBO 03-25-2025
- Dividend Yield
- CTRM N/A
- IBO N/A
- EPS Growth
- CTRM N/A
- IBO N/A
- EPS
- CTRM 2.39
- IBO 0.01
- Revenue
- CTRM $76,443,340.00
- IBO N/A
- Revenue This Year
- CTRM N/A
- IBO N/A
- Revenue Next Year
- CTRM N/A
- IBO N/A
- P/E Ratio
- CTRM $1.02
- IBO $70.35
- Revenue Growth
- CTRM N/A
- IBO N/A
- 52 Week Low
- CTRM $2.33
- IBO $0.55
- 52 Week High
- CTRM $5.49
- IBO $3.25
- Technical
- Relative Strength Index (RSI)
- CTRM 40.22
- IBO N/A
- Support Level
- CTRM $2.37
- IBO N/A
- Resistance Level
- CTRM $2.84
- IBO N/A
- Average True Range (ATR)
- CTRM 0.15
- IBO 0.00
- MACD
- CTRM 0.00
- IBO 0.00
- Stochastic Oscillator
- CTRM 15.69
- IBO 0.00
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.